Ironwood Pharmaceuticals (IRWD) PT Raised to $27 at Mizuho Securities
Tweet
Share
E-mailGet Alerts IRWD Hot Sheet
Price: $3.82 +7.91%
Rating Summary:
11 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 5
Rating Summary:
11 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 5
Join SI Premium – FREE
Mizuho Securities raised its price target on Ironwood Pharmaceuticals (NASDAQ: IRWD) to $27.00 (from $25.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Upgrades QIAGEN NV (QIA:GR) (QGEN) to Overweight
- Siemens Healthineers (SHL:GR) (SEMHF) PT Lowered to EUR37 at Morgan Stanley
- Deutsche Bank Downgrades Apogee Therapeutics Inc (APGE) to Hold
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
